Valrubicin(AD-32) is a chemotherapy drug
used to treat bladder cancer. Valrubicin is a chemotherapy agent,
inhibits TPA- and PDBu-induced PKC activation with IC50s of
0.85 and 1.25 μM, respectively.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.